| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 01/09/2003 | WO2003002524A2 Urea derivatives with antiproteolytic activity |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2003002491A2 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
| 01/09/2003 | WO2003002255A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/09/2003 | WO2002048092A3 Compounds for altering mitochondrial function and cellular responses |
| 01/09/2003 | WO2001072728B1 Novel piperazine derivatives |
| 01/09/2003 | US20030009046 Preparation of preparing substituted indanones |
| 01/09/2003 | US20030009038 Adding formaldehyde and terephthalic acid compound to fuming sulfuric acid containing al least 20% of SO3, heating the mixture, isolating carboxyphthalide compound |
| 01/09/2003 | US20030008913 For controlling harmful insects, acarids and nematodes |
| 01/09/2003 | US20030008884 Fungicidal phenyl (thio) urea and phenyl (thio) carbamate derivatives |
| 01/09/2003 | US20030008876 Can mimic or block the effect of extracellular calcium on a cell surface calcium receptor; for use in therapy |
| 01/09/2003 | US20030008232 (Meth)acrylate compounds having a norbornane, bicyclo(2.2.2) octane, 7-oxanorbornane or cyclohexane ring structure and a gamma-butyrolactone ring structure connected together by a linker, useful in forming polymer with high transparency |
| 01/08/2003 | EP1273577A1 Process for the preparation of o-xylene-naphthalene-air mixtures for the production of phthalic anhydride |
| 01/08/2003 | EP1273571A1 Nitrogenous compounds and antiviral drugs containing the same |
| 01/08/2003 | EP1273298A2 Ritonavir in combination with an additional HIV protease inhibitor for treating aids |
| 01/08/2003 | EP1272537A2 Ether-amine based polymerization catalysts, compositions and processes using same |
| 01/08/2003 | EP1272480A1 Method for the production of spirocyclic tetronic acid derivatives |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/08/2003 | EP1272176A1 Adamantyl derivatives as anti-cancer agents |
| 01/08/2003 | EP1124819B1 Method of lithiating five-membered heterocycles |
| 01/08/2003 | EP1123284B1 Method for the preparation of citalopram |
| 01/08/2003 | EP0996439B1 Beta-alkoxyacrylates against malaria |
| 01/08/2003 | EP0859768B1 Amine acid salt compounds and process for the production thereof |
| 01/08/2003 | CN1390212A Method for producing of benzofuranone oximes |
| 01/08/2003 | CN1390210A Process for preparing oxazolines from tetrahydrofurans |
| 01/08/2003 | CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/07/2003 | US6504055 Catalysts and processes for the conversion of succinates to citraconates or itaconates |
| 01/07/2003 | US6504036 2- and 2.5-substituted phenylketoenols |
| 01/07/2003 | US6504031 Enzyme inhibitor such as 6-(2-(1-isopropyl-1,2,3,4-tetrahydro -7-isoquinolinyl)ethenyl)-2-naphthalenecarboximidamide, used as angiogenesis inhibitors; antiarthritic, antiinflammatory and antitumor agents |
| 01/07/2003 | US6504015 Tetrahydrofuran-adducted group II β-diketonate complexes as source reagents for chemical vapor deposition |
| 01/07/2003 | US6504014 Tissue specific prodrug |
| 01/07/2003 | US6503949 Glucagon antagonists/inverse agonists |
| 01/07/2003 | US6503940 Prodrugs for antimicrobial amidines |
| 01/07/2003 | US6503929 Nitrate salt of anti-ulcer medicine |
| 01/07/2003 | CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease |
| 01/06/2003 | CA2392187A1 Combination preparation for the therapy of immunological diseases |
| 01/03/2003 | WO2003000672A1 Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram |
| 01/03/2003 | WO2003000671A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000649A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000646A1 Substituted aromatic ethers as inhibitors of glycine transport |
| 01/03/2003 | WO2003000262A1 Vinyl phenyl derivatives as glk activators |
| 01/03/2003 | WO2003000249A1 Function regulator for retinoid relative receptor |
| 01/03/2003 | WO2003000247A1 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 01/03/2003 | WO2002051828A3 Novel c-glycoside derivatives and use thereof |
| 01/03/2003 | CA2451673A1 Substituted aromatic ethers as inhibitors of glycine transport |
| 01/03/2003 | CA2450174A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | CA2449844A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/02/2003 | US20030004212 Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists |
| 01/02/2003 | US20030004151 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/02/2003 | US20030004090 For use as fragrance chemicals |
| 01/02/2003 | US20030000129 Transition-metal-catalyzed process for the preparation of sterically hindered N-substituted alkoxy amines |
| 01/02/2003 | EP1270565A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives |
| 01/02/2003 | EP1270554A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 01/02/2003 | EP1270551A1 Urea derivatives with antiproteolytic activity |
| 01/02/2003 | EP1270535A2 Method to synthesise substituted aromatic compounds |
| 01/02/2003 | EP1268461A1 Process for the preparation of citalopram |
| 01/02/2003 | EP1268460A2 Oxidaton of 5-(hydroxymethyl) furfural to 2,5-diformylfuran and subsequent decarbonylation to unsubstituted furan |
| 01/02/2003 | EP1268455A2 Piperazine derivatives |
| 01/02/2003 | EP1268430A1 Chemical complex compprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/02/2003 | EP1268397A2 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof |
| 01/02/2003 | EP1268096A1 Extrusion die |
| 01/02/2003 | EP1219614A9 Benzene sulfonamides as PDE-V inhibitors for the use against erectile dysfunction |
| 01/02/2003 | EP0828727B1 Cyclohexyl dihydrobenzofuranes |
| 01/02/2003 | EP0751939B9 Naphthylamides as central nervous system agents |
| 01/02/2003 | EP0630366B1 Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| 01/01/2003 | CN1097589C Process for purifying 2-benzo [C] furanone |
| 01/01/2003 | CN1097588C Dihydrobenzofuran and related compounds used as anti-inflammatory agents |
| 01/01/2003 | CN1097587C Dihydrobenzofuran and related compound used as anti-inflammatory agent |
| 12/31/2002 | US6500962 Production method of α-methylene-γ-butyrolactones |
| 12/31/2002 | US6500961 Microstructure patterns for photoresists |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome |
| 12/27/2002 | WO2002103826A2 Zinc anode for electrochemical cells |
| 12/27/2002 | WO2002102803A1 Total synthesis of galanthamine, analogues and derivatives thereof |
| 12/27/2002 | WO2002102788A1 Crystalline salts of benzoylbenzofuran-derivatives |
| 12/27/2002 | WO2002102765A2 Protected tyrosine derivatives, method for the production thereof and use of the same for producing o-(2-[18f]-fluoroethyl)-l-tyrosine |
| 12/27/2002 | WO2002102756A2 Polyimides comprising cf2o structural elements |
| 12/27/2002 | WO2002102389A1 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 12/27/2002 | WO2001023352A9 Preparation of sulfonyl imine compounds |
| 12/26/2002 | US20020198391 Method for the preparation of citalopram |
| 12/26/2002 | US20020198390 Acrylic esters containing fluorine at alpha-position and having a lactone ring introduced into the ester side chain thereof; useful as monomers to produce base polymers for use in chemically amplified resist compositions |
| 12/26/2002 | US20020198388 Sulfonamides which are aspartyl protease inhibitors; well suited for inhibiting HIV-1 and HIV-2 protease activity |
| 12/26/2002 | US20020198383 For use in regioselective and enantioselective alkylations of allylic substrates |
| 12/26/2002 | US20020198251 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/26/2002 | US20020198207 Novel Hexanoic acid derivatives |
| 12/26/2002 | US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 12/25/2002 | CN1387518A Heterocyclic substd, diphenyl leukotriene antagonists |
| 12/25/2002 | CN1387507A Diaryl-enynes |
| 12/25/2002 | CN1386739A Process for dewatering and prifying tetrahydrofuran |
| 12/25/2002 | CN1097052C Process for production of amidinoindole derivs, and salts thereof |
| 12/25/2002 | CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides |
| 12/25/2002 | CN1097047C Process for preparing phthalides |
| 12/25/2002 | CN1097046C Process of preparing phenyl heterocycles useful as COX-2 inhibitors |
| 12/25/2002 | CN1097045C Butyolactone preparation process |
| 12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/24/2002 | US6498258 3-acetyl-N-substituted-3-aminomethyltetrahydrofuran-2-one derivative and production process therefor |
| 12/24/2002 | US6498224 Methods for the preparation poly(etherimide)s |
| 12/24/2002 | US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same |